At Quanta BioSciences their goal is simple - to provide best-in-class qPCR reagents enabling sophisticated applications in life science and drug discovery laboratories throughout the world. Their real time PCR and cDNA synthesis reagents define the standard for the reproducibility, specificity and sensitivity needed by researchers using these techniques.

Quanta BioSciences has developed a comprehensive line of qPCR reagents for TaqMan® Probe Detection and SYBR® Green Detection as well as cDNA, qRT-PCR and PCR reagents for use in applications such as:

• ·         Gene Expression Profiling
• ·         Knock-down confirmation
• ·         SNP Genotyping
• ·         Biomarker Discovery/Validation
• ·         Array validation

Founding members of Quanta BioSciences have a legacy of leading the development of pioneering reagents including Invitrogen’s SuperScript® 1-Step RT-PCR Kits, Platinum® Taq, and Bio-Rad's iScript™, and iQ™/iTaq™ SuperMixes.

Inspiring Quanta's progressive and ingenious approach to qPCR technology is a dedication to design excellence. This commitment is supported by proven technical expertise and an innate desire to explore, discover and perfect.
With the enthusiasm, flexibility and reliability of a true collaborator, Quanta has an unwavering commitment to Perfecting qPCR. 

Quanta has acquired a license for PCR from Applied Biosystems, an Applera Corporation
The agreement enables Quanta BioSciences to offer optimized reagents and kits for PCR and Real-Time PCR that utilize SYBR Green and probe- based methods. The agreement also allows Quanta BioSciences to develop Real-Time PCR reagents and technologies and to pass on rights to end-user customers in the research field.

SuperScript® and Platinum®Taq are registered trademarks of Invitrogen Corporation. iScript™, iQ™ and iTaq™ are trademarks of Bio-Rad Laboratories, Inc.